The effect of ESR1 and ESR2 gene polymorphisms on the outcome of rheumatoid arthritis treatment with leflunomide

Author： Dziedziejko Violetta Kurzawski Mateusz Safranow Krzysztof Chlubek Dariusz Pawlik Andrzej

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.12, Iss.1, 2011-01, pp. : 41-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

ESR1, ESR2 and FSH Receptor Gene Polymorphisms in Combination: A Useful Genetic Tool for the Prediction of Poor Responders

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 3, 2012-03 ,pp. : 426-434

Bentham Science Publishers

Access to resources Recommend Favorite

Leflunomide for the treatment of rheumatoid arthritis

By Miceli-Richard Corinne Dougados Maxime

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 987-997

Informa Healthcare

Access to resources Recommend Favorite

The effect of exon (19C>A) dihydroorotate dehydrogenase gene polymorphism on rheumatoid arthritis treatment with leflunomide

By Pawlik Andrzej Herczynska Magdalena Kurzawski Mateusz Safranow Krzysztof Dziedziejko Violetta Drozdzik Marek

Pharmacogenomics, Vol. 10, Iss. 2, 2009-02 ,pp. : 303-309

Future Medicine

Access to resources Recommend Favorite

Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis

By Kooloos Wouter M Wessels Judith AM van der Straaten Tahar Allaart Cornelia F Huizinga Tom WJ Guchelaar Henk-Jan

Pharmacogenomics, Vol. 11, Iss. 2, 2010-02 ,pp. : 163-175

Future Medicine

Access to resources Recommend Favorite

Leflunomide: a novel DMARD for the treatment of rheumatoid arthritis

By Alldred A. Emery P.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 1, 2001-01 ,pp. : 125-137

Informa Healthcare

Access to resources Recommend Favorite